As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

The Centers for Medicare and Medicaid Services did not explain why it was not finalizing the proposal, which the Biden ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump officials reject Medicare coverage ...

Eastern states took the top spots on WalletHub's rankings of "best" states for children's health. Here's where Washington ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the ...

WASHINGTON -- The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded coverage of costly anti-obesity drugs to more than 7 ...